γδ T cells: A new frontier for immunotherapy?
Open Access
- 31 March 2005
- journal article
- review article
- Published by Elsevier
- Vol. 11 (3) , 161-168
- https://doi.org/10.1016/j.bbmt.2004.11.015
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Antitumor Immunization with a Minimal Peptide Epitope (G9–209–2M) Leads to a Functionally Heterogeneous CTL ResponseJournal of Immunotherapy, 1999
- Enhancing effect of tumor necrosis factor (TNF)-α, but not IFN-γ, on the tumor-specific cytotoxicity of γδT cells from glioblastoma patientsCancer Letters, 1999
- Rapid Communication: Increased Frequency of TCRγδ+ T Cells in Disease-Free Survivors Following T Cell-Depleted, Partially Mismatched, Related Donor Bone Marrow Transplantation for LeukemiaPublished by Mary Ann Liebert Inc ,1996
- γδ T cells are secondary participants in acute graft-versus-host reactions initiated by CD4+ αβT cellsEuropean Journal of Immunology, 1996
- Accumulation of γ/δ T Cells in Human Dysgerminoma and Seminoma: Roles in Autologous Tumor Killing and Granuloma FormationImmunological Investigations, 1995
- Activation and function of γδ T cellsCurrent Opinion in Immunology, 1994
- Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodiesCancer Immunology, Immunotherapy, 1990
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Antigen-presenting properties of human epidermal cells compared with peripheral blood mononuclear cellsBritish Journal of Dermatology, 1985